William T. Abraham
Ohio State University
697 Papers
4.1K Citations
William T. Abraham is an academic researcher from Ohio State University. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 111, co-authored 647 publications. Previous affiliations of William T. Abraham include Truman Medical Center & Free University of Berlin.
Chat about Author
Papers
Cardiac Resynchronization in Chronic Heart Failure
William T. Abraham,Westby G. Fisher,Andrew L. Smith,David B. Delurgio,Angel R. Leon,Evan Loh,Dusan Z. Kocovic,Milton Packer,Alfredo L. Clavell,David L. Hayes,Myrvin H. Ellestad,Robin J. Trupp,Jackie Underwood,Faith Pickering,Cindy Truex,Peggy McAtee,John C. Messenger +16 more
TL;DR: Cardiac resynchronization results in significant clinical improvement in patients who have moderate-to-severe heart failure and an intraventricular conduction delay.
4.6K
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
Alan S. Maisel,Padma Krishnaswamy,Richard M. Nowak,James McCord,Judd E. Hollander,Philippe Duc,Torbjørn Omland,Alan B. Storrow,William T. Abraham,Alan H.B. Wu,Paul Clopton,Philippe Gabriel Steg,Arne Westheim,Catherine W. Knudsen,Alberto Perez,Radmila Kazanegra,Howard C. Herrmann,Peter A. McCullough +17 more
TL;DR: Used in conjunction with other clinical information, rapid measurement of B-type natriuretic peptide is useful in establishing or excluding the diagnosis of congestive heart failure in patients with acute dyspnea.
3.4K
Transcatheter Mitral-Valve Repair in Patients with Heart Failure.
Gregg W. Stone,JoAnn Lindenfeld,William T. Abraham,Saibal Kar,D. Scott Lim,Jacob M. Mishell,Brian Whisenant,Paul A. Grayburn,Michael Rinaldi,Samir R. Kapadia,Vivek Rajagopal,Ian J. Sarembock,Andreas Brieke,Steven O. Marx,David J. Cohen,Neil J. Weissman,Michael J. Mack +16 more
TL;DR: Among patients with heart failure and moderate‐to‐severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline‐directed medical therapy, transcatheter mitral‐valve repair resulted in a lower rate of hospitalization forHeart failure and lower all‐cause mortality within 24 months of follow‐up than medical therapy alone.
2.4K
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
Henry Krum,Markus P. Schlaich,Robert Whitbourn,Paul A. Sobotka,Jerzy Sadowski,Krzysztof Bartus,Bogusław Kapelak,Anthony Walton,Horst Sievert,S. Thambar,William T. Abraham,Murray D. Esler +11 more
TL;DR: In this article, a proof-of-principle trial of therapeutic renal sympathetic denervation in patients with resistant hypertension (i.e., systolic blood pressure ≥160 mm/hg on three or more antihypertensive medications, including a diuretic) was conducted to assess safety and blood-pressure reduction effectiveness.
2.3K
Cardiac resynchronization in chronic heart failure
TL;DR: Cardiac resynchronization results in significant clinical improvement in patients who have moderate-to-severe heart failure and an intraventricular conduction delay.
2.3K